127 related articles for article (PubMed ID: 37857130)
1. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
[TBL] [Abstract][Full Text] [Related]
2. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
[TBL] [Abstract][Full Text] [Related]
3. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative.
Kurian AW; Hughes E; Simmons T; Bernhisel R; Probst B; Meek S; Caswell-Jin JL; John EM; Lanchbury JS; Slavin TP; Wagner S; Gutin A; Rohan TE; Shadyab AH; Manson JE; Lane D; Chlebowski RT; Stefanick ML
Cancer; 2021 Oct; 127(20):3742-3750. PubMed ID: 34228814
[TBL] [Abstract][Full Text] [Related]
4. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40-49 years - could it be better?
Oblak T; Zadnik V; Krajc M; Lokar K; Zgajnar J
Radiol Oncol; 2020 Jul; 54(3):335-340. PubMed ID: 32614783
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Breast Cancer Risk Assessment for
Gallagher S; Hughes E; Kurian AW; Domchek SM; Garber J; Probst B; Morris B; Tshiaba P; Meek S; Rosenthal E; Roa B; Slavin TP; Wagner S; Weitzel J; Gutin A; Lanchbury JS; Robson M
JCO Precis Oncol; 2021 Jun; 5():. PubMed ID: 34322652
[TBL] [Abstract][Full Text] [Related]
8. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
9. Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing.
Hughes E; Tshiaba P; Wagner S; Judkins T; Rosenthal E; Roa B; Gallagher S; Meek S; Dalton K; Hedegard W; Adami CA; Grear DF; Domchek SM; Garber J; Lancaster JM; Weitzel JN; Kurian AW; Lanchbury JS; Gutin A; Robson ME
JCO Precis Oncol; 2021; 5():. PubMed ID: 34036224
[TBL] [Abstract][Full Text] [Related]
10. Use of Receiver Operating Characteristic (ROC) Curve Analysis for Tyrer-Cuzick and Gail in Breast Cancer Screening in Jiangxi Province, China.
Zhang L; Jie Z; Xu S; Zhang L; Guo X
Med Sci Monit; 2018 Aug; 24():5528-5532. PubMed ID: 30089770
[TBL] [Abstract][Full Text] [Related]
11. Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines - Pilot Study.
Krajc M; Gareth Evans D; Blatnik A; Lokar K; Žagar T; Tomšič S; Žgajnar J; Zadnik V
Zdr Varst; 2020 Dec; 59(4):211-218. PubMed ID: 33133277
[TBL] [Abstract][Full Text] [Related]
12. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
Boughey JC; Hartmann LC; Anderson SS; Degnim AC; Vierkant RA; Reynolds CA; Frost MH; Pankratz VS
J Clin Oncol; 2010 Aug; 28(22):3591-6. PubMed ID: 20606088
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study.
Jarm K; Zadnik V; Birk M; Vrhovec M; Hertl K; Klanecek Z; Studen A; Sval C; Krajc M
Radiol Oncol; 2023 Sep; 57(3):337-347. PubMed ID: 37665745
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
[TBL] [Abstract][Full Text] [Related]
16. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.
Kim JO; Schaid DJ; Vachon CM; Cooke A; Couch FJ; Kim CA; Sinnwell JP; Hasadsri L; Stan DL; Goldenberg B; Neal L; Grenier D; Degnim AC; Thicke LA; Pruthi S
Cancer Prev Res (Phila); 2021 Feb; 14(2):175-184. PubMed ID: 33097489
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.
Collister JA; Liu X; Littlejohns TJ; Cuzick J; Clifton L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):812-820. PubMed ID: 38630597
[TBL] [Abstract][Full Text] [Related]
18. An integrated breast cancer risk assessment and management model based on fuzzy cognitive maps.
Subramanian J; Karmegam A; Papageorgiou E; Papandrianos N; Vasukie A
Comput Methods Programs Biomed; 2015 Mar; 118(3):280-97. PubMed ID: 25697987
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
Li H; Feng B; Miron A; Chen X; Beesley J; Bimeh E; Barrowdale D; John EM; Daly MB; Andrulis IL; Buys SS; Kraft P; ; Thorne H; Chenevix-Trench G; Southey MC; Antoniou AC; James PA; Terry MB; Phillips KA; Hopper JL; Mitchell G; Goldgar DE
Genet Med; 2017 Jan; 19(1):30-35. PubMed ID: 27171545
[TBL] [Abstract][Full Text] [Related]
20. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
